K800203

Substantially Equivalent

RIA PHASE T4

Applicant: Boehringer Mannheim Corp.
Product code: CDX
Advisory panel: Clinical Chemistry
Date received: 1980-01-30
Decision date: 1980-03-19
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Walker, MI, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.